Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease
- PMID: 17524628
- DOI: 10.1016/j.pscychresns.2006.12.003
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease
Abstract
While significantly reduced glucose metabolism in fronto-temporo-parietal and cingulate cortices has been demonstrated in Alzheimer's disease (AD) compared with controls, cerebral glucose metabolism in patients with mild cognitive impairment who subsequently develop AD is less well-defined. In the present study we measured cerebral glucose metabolism by positron emission tomography (PET) with (18)F-2-fluoro-2-deoxy-D-glucose in 14 patients with aging-associated cognitive decline (AACD), 44 patients with AD, and 14 healthy control subjects at baseline. The AACD patients were clinically followed up, and conversion to AD was determined. Compared with controls, AACD patients had significantly reduced glucose metabolism in the right precuneus, posterior cingulate, right angular gyrus, and bilateral middle temporal cortices, while the respective deficits were more pronounced in AD patients and also involved the frontal cortices. AACD patients who subsequently converted to AD (AACD-converters) showed more extended metabolic changes which also involved the frontal and temporal cortices, right cingulate gyrus, right thalamus, and bilateral precuneus.
Similar articles
-
Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.Neurosci Lett. 2013 Feb 8;534:12-7. doi: 10.1016/j.neulet.2012.11.026. Epub 2012 Nov 23. Neurosci Lett. 2013. PMID: 23182881
-
Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.J Neurotrauma. 2007 Jun;24(6):919-26. doi: 10.1089/neu.2006.0203. J Neurotrauma. 2007. PMID: 17600509
-
Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.Int Psychogeriatr. 2009 Feb;21(1):148-56. doi: 10.1017/S1041610208008132. Epub 2008 Dec 1. Int Psychogeriatr. 2009. PMID: 19040787
-
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. doi: 10.1007/s00259-005-1762-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747152 Review.
-
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.Expert Rev Neurother. 2010 Nov;10(11):1667-73. doi: 10.1586/ern.10.136. Expert Rev Neurother. 2010. PMID: 20977325 Review.
Cited by
-
Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence.Alzheimers Dement (N Y). 2021 May 18;7(1):e12177. doi: 10.1002/trc2.12177. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 34027027 Free PMC article.
-
Blood-Brain Barrier: From Physiology to Disease and Back.Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017. Physiol Rev. 2019. PMID: 30280653 Free PMC article. Review.
-
Prediction and Modeling of Neuropsychological Scores in Alzheimer's Disease Using Multimodal Neuroimaging Data and Artificial Neural Networks.Front Comput Neurosci. 2022 Jan 6;15:769982. doi: 10.3389/fncom.2021.769982. eCollection 2021. Front Comput Neurosci. 2022. PMID: 35069161 Free PMC article.
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):36-45. doi: 10.1007/s00259-009-1218-6. Eur J Nucl Med Mol Imaging. 2010. PMID: 19662411
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
